Statins and their potential targets in multiple sclerosis therapy

Author： Stüve Olaf   Prod’homme Thomas   Slavin Anthony   Youssef Sawsan   Dunn Shannon   Steinman Lawrence   Zamvil Scott S  

Publisher： Informa Healthcare

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.7, Iss.5, 2003-10, pp. : 613-622

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Chemokines and Chemokine Receptors: Potential Therapeutic Targets in Multiple Sclerosis

By  

Current Drug Targets. Inflammation & Allergy, Vol. 3, Iss. 3, 2004-01 ,pp. : 279-290

Bentham Science Publishers

Access to resources Recommend Favorite

Potential of -Adrenoceptor Agonists as Add-On Therapy for Multiple Sclerosis: Focus on Salbutamol (Albuterol)

By Makhlouf K.   Weiner H.L.   Khoury S.J.  

CNS Drugs, Vol. 16, Iss. 1, 2002-01 ,pp. : 1-8

Adis International

Access to resources Recommend Favorite

Genomics and new targets for multiple sclerosis

By Baranzini Sergio E   Oksenberg Jorge R  

Pharmacogenomics, Vol. 6, Iss. 2, 2005-03 ,pp. : 151-161

Future Medicine

Access to resources Recommend Favorite

The therapeutic potential of cannabis in multiple sclerosis

By Baker David   Pryce Gareth  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 4, 2003-04 ,pp. : 561-567

Informa Healthcare

Access to resources Recommend Favorite

Advances in Antioxidative Therapy of Multiple Sclerosis

By  

Current Medicinal Chemistry, Vol. 20, Iss. 37, 2013-11 ,pp. : 4720-4730

Bentham Science Publishers

Access to resources Recommend Favorite